These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1511 related articles for article (PubMed ID: 33936746)

  • 81. Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020.
    Decaro N; Vaccari G; Lorusso A; Lorusso E; De Sabato L; Patterson EI; Di Bartolo I; Hughes GL; Teodori L; Desario C; Colitti B; Ricci D; Buonavoglia D; Rosati S; Martella V; Cammà C; Agrimi U; Elia G
    Emerg Infect Dis; 2021; 27(7):1981-1984. PubMed ID: 33979566
    [TBL] [Abstract][Full Text] [Related]  

  • 82. COVID-19 Outbreak on a Passenger Ship and Assessment of Response Measures, Greece, 2020.
    Hatzianastasiou S; Mouchtouri VA; Pavli A; Tseroni M; Sapounas S; Vasileiou C; Dadouli K; Kyritsi M; Koureas M; Prezerakos P; Speletas M; Panagiotakopoulos G; Tsiodras S; Hadjichristodoulou C
    Emerg Infect Dis; 2021 Jul; 27(7):1927-1930. PubMed ID: 33979565
    [TBL] [Abstract][Full Text] [Related]  

  • 83. High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.
    Hoepel W; Chen HJ; Geyer CE; Allahverdiyeva S; Manz XD; de Taeye SW; Aman J; Mes L; Steenhuis M; Griffith GR; Bonta PI; Brouwer PJM; Caniels TG; van der Straten K; Golebski K; Jonkers RE; Larsen MD; Linty F; Nouta J; van Roomen CPAA; van Baarle FEHP; van Drunen CM; Wolbink G; Vlaar APJ; de Bree GJ; Sanders RW; Willemsen L; Neele AE; van de Beek D; Rispens T; Wuhrer M; Bogaard HJ; van Gils MJ; Vidarsson G; de Winther M; den Dunnen J
    Sci Transl Med; 2021 Jun; 13(596):. PubMed ID: 33979301
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cruise Ship Travel in the Era of Coronavirus Disease 2019 (COVID-19): A Summary of Outbreaks and a Model of Public Health Interventions.
    Guagliardo SAJ; Prasad PV; Rodriguez A; Fukunaga R; Novak RT; Ahart L; Reynolds J; Griffin I; Wiegand R; Quilter LAS; Morrison S; Jenkins K; Wall HK; Treffiletti A; White SB; Regan J; Tardivel K; Freeland A; Brown C; Wolford H; Johansson MA; Cetron MS; Slayton RB; Friedman CR
    Clin Infect Dis; 2022 Feb; 74(3):490-497. PubMed ID: 33978720
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Green and white teas as health-promoting foods.
    Hinojosa-Nogueira D; Pérez-Burillo S; Pastoriza de la Cueva S; Rufián-Henares JÁ
    Food Funct; 2021 May; 12(9):3799-3819. PubMed ID: 33977999
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review.
    Cabrera Martimbianco AL; Pacheco RL; Bagattini ÂM; Riera R
    Int J Clin Pract; 2021 Oct; 75(10):e14357. PubMed ID: 33977626
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up.
    Gamberini L; Mazzoli CA; Sintonen H; Colombo D; Scaramuzzo G; Allegri D; Tonetti T; Zani G; Capozzi C; Giampalma E; Agnoletti V; Becherucci F; Bertellini E; Castelli A; Cappellini I; Cavalli I; Crimaldi F; Damiani F; Fusari M; Gordini G; Laici C; Lanza MC; Leo M; Marudi A; Nardi G; Ottaviani I; Papa R; Potalivo A; Ranieri VM; Russo E; Taddei S; Volta CA; Spadaro S;
    Qual Life Res; 2021 Oct; 30(10):2805-2817. PubMed ID: 33977415
    [TBL] [Abstract][Full Text] [Related]  

  • 88. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
    Yamada T; Sato S; Sotoyama Y; Orba Y; Sawa H; Yamauchi H; Sasaki M; Takaoka A
    Nat Immunol; 2021 Jul; 22(7):820-828. PubMed ID: 33976430
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Detecting infected asymptomatic cases in a stochastic model for spread of Covid-19: the case of Argentina.
    Barreiro NL; Govezensky T; Bolcatto PG; Barrio RA
    Sci Rep; 2021 May; 11(1):10024. PubMed ID: 33976342
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease.
    AlQahtani M; Abdulrahman A; Almadani A; Alali SY; Al Zamrooni AM; Hejab AH; Conroy RM; Wasif P; Otoom S; Atkin SL; Abduljalil M
    Sci Rep; 2021 May; 11(1):9927. PubMed ID: 33976287
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
    Prats-Uribe A; Sena AG; Lai LYH; Ahmed WU; Alghoul H; Alser O; Alshammari TM; Areia C; Carter W; Casajust P; Dawoud D; Golozar A; Jonnagaddala J; Mehta PP; Gong M; Morales DR; Nyberg F; Posada JD; Recalde M; Roel E; Shah K; Shah NH; Schilling LM; Subbian V; Vizcaya D; Zhang L; Zhang Y; Zhu H; Liu L; Cho J; Lynch KE; Matheny ME; You SC; Rijnbeek PR; Hripcsak G; Lane JC; Burn E; Reich C; Suchard MA; Duarte-Salles T; Kostka K; Ryan PB; Prieto-Alhambra D
    BMJ; 2021 May; 373():n1038. PubMed ID: 33975825
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern.
    Bezerra MF; Machado LC; De Carvalho VDCV; Docena C; Brandão-Filho SP; Ayres CFJ; Paiva MHS; Wallau GL
    Infect Genet Evol; 2021 Aug; 92():104910. PubMed ID: 33975021
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Ioannou GN; O'Hare AM; Berry K; Fan VS; Crothers K; Eastment MC; Locke E; Green P; Shah JA; Dominitz JA
    Clin Infect Dis; 2022 Feb; 74(3):416-426. PubMed ID: 33973000
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Smartphone science: apps test and track infectious diseases.
    Ravindran S
    Nature; 2021 May; 593(7858):302-303. PubMed ID: 33972778
    [No Abstract]   [Full Text] [Related]  

  • 95. Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.
    León G; Herrera M; Vargas M; Arguedas M; Sánchez A; Segura Á; Gómez A; Solano G; Corrales-Aguilar E; Risner K; Narayanan A; Bailey C; Villalta M; Hernández A; Sánchez A; Cordero D; Solano D; Durán G; Segura E; Cerdas M; Umaña D; Moscoso E; Estrada R; Gutiérrez J; Méndez M; Castillo AC; Sánchez L; Sánchez R; Gutiérrez JM; Díaz C; Alape A
    Sci Rep; 2021 May; 11(1):9825. PubMed ID: 33972631
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
    Saunders KO; Lee E; Parks R; Martinez DR; Li D; Chen H; Edwards RJ; Gobeil S; Barr M; Mansouri K; Alam SM; Sutherland LL; Cai F; Sanzone AM; Berry M; Manne K; Bock KW; Minai M; Nagata BM; Kapingidza AB; Azoitei M; Tse LV; Scobey TD; Spreng RL; Rountree RW; DeMarco CT; Denny TN; Woods CW; Petzold EW; Tang J; Oguin TH; Sempowski GD; Gagne M; Douek DC; Tomai MA; Fox CB; Seder R; Wiehe K; Weissman D; Pardi N; Golding H; Khurana S; Acharya P; Andersen H; Lewis MG; Moore IN; Montefiori DC; Baric RS; Haynes BF
    Nature; 2021 Jun; 594(7864):553-559. PubMed ID: 33971664
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans.
    Burkholz S; Pokhrel S; Kraemer BR; Mochly-Rosen D; Carback RT; Hodge T; Harris P; Ciotlos S; Wang L; Herst CV; Rubsamen R
    Infect Genet Evol; 2021 Sep; 93():104897. PubMed ID: 33971305
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
    Schroeder S; Pott F; Niemeyer D; Veith T; Richter A; Muth D; Goffinet C; Müller MA; Drosten C
    Lancet Microbe; 2021 May; 2(5):e210-e218. PubMed ID: 33969329
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions.
    Mahapatra S; Rattan R; Mohanty CBK
    Transfus Clin Biol; 2021 Aug; 28(3):246-253. PubMed ID: 33965621
    [TBL] [Abstract][Full Text] [Related]  

  • 100. COVIDOUTCOME-estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome.
    Nagy Á; Ligeti B; Szebeni J; Pongor S; Gyrffy B
    Database (Oxford); 2021 May; 2021():. PubMed ID: 33963845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.